(Q43680908)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

25 November 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance. (English)

1 reference

25 November 2017

1 reference

H Thakkar

1

1 reference

25 November 2017

X Chen

2

1 reference

25 November 2017

F Tyan

3

1 reference

25 November 2017

S Gim

4

1 reference

25 November 2017

H Robinson

5

1 reference

25 November 2017

C Lee

6

1 reference

25 November 2017

S K Pandey

7

1 reference

25 November 2017

C Nwokorie

8

1 reference

25 November 2017

N Onwudiwe

9

1 reference

25 November 2017

R K Srivastava

10

1 reference

25 November 2017

language of work or name

English

0 references

publication date

18 July 2001

1 reference

Journal of Biological Chemistry

25 November 2017

1 reference

25 November 2017

276

1 reference

25 November 2017

38361-38369

1 reference

25 November 2017

42

1 reference

25 November 2017

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Chemotherapy for advanced hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Anti-androgens and other hormonal therapies for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Intracellular mechanisms of TRAIL and its role in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

The TRAIL to selective tumor death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Human astrocytic brain tumors express AP02L/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Apoptosis control by death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Mitochondria and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)-terminal kinase activity, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Cellular survival: a play in three Akts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Effect of phosphoinositide-dependent kinase 1 on protein kinase B translocation and its subsequent activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

The activation of protein kinase B by H2O2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Regulation of cell death protease caspase-9 by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Direct control of the Forkhead transcription factor AFX by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Regulation of neuronal survival by the serine-threonine protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

PTEN/MMAC1/TEP1 involvement in primary prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

PTEN: a tumour suppressor that functions as a phospholipid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

The multiple roles of PTEN in tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Removal of endotoxin from recombinant protein preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Mechanisms and consequences of activation of protein kinase B/Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Mitochondrial control of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Negative regulation of the forkhead transcription factor FKHR by Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Molecular characterization of mitochondrial apoptosis-inducing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Two CD95 (APO-1/Fas) signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Death and survival signals determine active/inactive conformations of pro-apoptotic BAX, BAD, and BID molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

Signalling by proteolysis: death receptors induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M103321200

TRAIL: a molecule with multiple receptors and control mechanisms

21 January 2018

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

Removal of endotoxin from protein solutions by phase separation using Triton X-114

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

The point of no return: mitochondria, caspases, and the commitment to cell death.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

Chromosome 10 alterations in prostate adenocarcinoma (review)

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

How TRAIL kills cancer cells, but not normal cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1074/JBC.M103321200

Identifiers

DOI

10.1074/JBC.M103321200

1 reference

25 November 2017

1 reference